Effects of rasagiline on Parkinson's Disease Questionnaire (PDQ-39) emotional well-being domain in patients with Parkinson's disease: A post-hoc analysis of clinical trials in Japan.
Nobutaka HattoriAtsushi TakedaYuki HanyaTadayuki KitagawaMasaki AraiYoshihiko FurusawaHideki MochizukiMasahiro NagaiRyosuke TakahashiPublished in: PloS one (2022)
The effects of rasagiline on the PDQ-39 emotional well-being domain were mediated primarily by influence on the subjective aspects of motor experiences of daily living.